Similar articles

• [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].

  Jacus JP, Dupont MP, Herades Y, Pelix C, Large H, Baud M. Jacus JP, et al. Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11. Encephale. 2014. PMID: 24630532 Review. French.
• Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

  Okamura N, Arai H, Maruyama M, Higuchi M, Matsui T, Tanji H, Seki T, Hirai H, Chiba H, Itoh M, Sasaki H. Okamura N, et al. Am J Psychiatry. 2002 Mar;159(3):474-6. doi: 10.1176/appi.ajp.159.3.474. Am J Psychiatry. 2002. PMID: 11870015
• Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

  Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. Devanand DP, et al. Am J Psychiatry. 2000 Sep;157(9):1399-405. doi: 10.1176/appi.ajp.157.9.1399. Am J Psychiatry. 2000. PMID: 10964854
• MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.

  Banerjee G, Kim HJ, Fox Z, Jäger HR, Wilson D, Charidimou A, Na HK, Na DL, Seo SW, Werring DJ. Banerjee G, et al. Brain. 2017 Apr 1;140(4):1107-1116. doi: 10.1093/brain/awx003. Brain. 2017. PMID: 28335021
• NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

  Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. Jack CR Jr, et al. Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.